YOLFTbeta
Cyclopharm Ltd

Cyclopharm Ltd

CYC · AU · Healthcare / Medical Devices

0.46AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.46
Open0.48
Day Range0.46 – 0.48
52-Week Range0.44 – 1.29
Volume23.07K
Market Cap55.32M
P/E (TTM)0.00
Forward P/E116.28
EPS-0.16
Dividend Yield0.00%
Beta0.59
50-Day Avg0.5082
200-Day Avg0.7021

About

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDM
  • Employees104
  • Headquarters1 The Crescent, Kingsgrove, NSW, Australia, 2208, Australia
  • Websitehttps://www.cyclomedica.com/company/cyclopharm/

Leadership

  • Mr. James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDMCEO, MD, Company Secretary & Director · b. 1965
  • Mr. Jason SmithChief Financial Officer
  • Mr. Mathew FaragChief Operating Officer
  • Ms. Sally-Ann CorneliusHead of Sales
  • Ms. Niamh McAreeHead of Quality and Regulatory
  • Mr. Chris QuinnHead of Service
  • Ms. Sui Ling CheahFinancial Controller · b. 1970
  • Mr. Lynn McLauchlinGeneral Manager of Canada
  • Mr. Gary T. SomervilleQuality & Regulatory Manager

Financials

Income Statement

Currency: AUD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue8.77M9.13M10.33M11.13M10.89M13.11M9.46M10.31M10.74M11.88M12.05M12.58M14.39M13.19M13.40M14.08M14.68M17.70M23.22M26.34M27.57M32.33M
Growth (%)-+4.08%+13.21%+7.71%-2.16%+20.43%-27.82%+8.98%+4.16%+10.60%+1.39%+4.45%+14.33%-8.32%+1.63%+5.03%+4.24%+20.63%+31.15%+13.44%+4.68%+17.24%
Cost of Revenue3.48M2.03M5.14M3.12M2.53M2.55M2.31M3.13M3.35M3.51M3.43M6.12M7.24M6.84M7.76M9.21M12.60M14.50M17.28M22.64M9.64M33.78M
Gross Profit--5.19M8.01M8.36M10.57M7.16M7.19M7.40M8.37M8.62M6.46M7.15M6.35M5.64M4.87M2.08M3.20M5.94M16.08M17.93M-1.46M
Gross Margin--50.24%71.95%76.75%80.58%75.60%69.68%68.83%70.47%71.55%51.35%49.68%48.17%42.11%34.56%14.17%18.09%25.58%61.06%65.04%-4.51%
Operating Expense--2.58M6.39M6.21M7.17M6.15M8.02M8.02M9.03M5.04M3.88M5.12M7.70M8.18M10.76M6.25M9.64M13.22M21.35M32.28M16.72M
Operating Income2.83M3.10M2.62M1.61M2.15M3.40M1.01M-836.73K-627.07K-655.74K3.58M2.58M2.02M-1.35M-2.54M-5.89M-4.17M-6.43M-7.28M-5.26M-14.35M-18.18M
Operating Margin32.25%34.02%25.31%14.50%19.75%25.90%10.64%-8.11%-5.84%-5.52%29.70%20.48%14.06%-10.23%-18.95%-41.84%-28.40%-36.34%-31.35%-19.98%-52.03%-56.25%
EBITDA--2.72M1.93M2.48M3.16M1.67M416.15K24.91K-8.62M871.28K4.26M1.55M-1.35M-1.47M-1.38M-7.73M-5.79M-6.47M-3.84M-13.69M-16.41M
EBITDA Margin--26.37%17.33%22.79%24.06%17.63%4.03%0.23%-72.55%7.23%33.86%10.74%-10.22%-10.95%-9.79%-52.68%-32.70%-27.86%-14.56%-49.65%-50.77%
Net Income2.15M1.58M2.03M1.13M1.76M2.04M450.11K-956.22K-1.04M-779.95K4.07M4.79M891.37K-1.52M-35.46K-2.91M-6.04M-5.04M-6.61M-4.70M-13.20M-17.22M
Net Income Margin24.49%17.34%19.63%10.17%16.14%15.59%4.76%-9.27%-9.72%-6.56%33.75%38.09%6.20%-11.56%-0.26%-20.69%-41.18%-28.47%-28.47%-17.85%-47.87%-53.27%
R&D34.00K32.00K20.16K28.76K35.99K39.73K16.85K68.00K22.74K37.51K14.23K726.99K1.16M2.87M3.22M4.19M3.54M1.66M3.44M3.69M365.02K614.69K
R&D as % of Total Revenue0.39%0.35%0.20%0.26%0.33%0.30%0.18%0.66%0.21%0.32%0.12%5.78%8.05%21.77%24.02%29.78%24.10%9.38%14.82%14.01%1.32%1.90%
Interest Expense00286.86K223.61K253.96K137.50K198.30K355.24K383.79K270.26K107.26K25.42K17.95K20.08K26.13K280.26K207.86K89.31K265.92K215.99K319.10K626.26K
Interest Expense % of Total Revenue0.00%0.00%2.78%2.01%2.33%1.05%2.10%3.44%3.57%2.27%0.89%0.20%0.12%0.15%0.19%1.99%1.42%0.50%1.15%0.82%1.16%1.94%

Balance Sheet

Currency: AUD2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets20.99M9.06M10.98M18.58M19.64M22.14M21.29M21.66M9.01M10.96M16.54M16.41M23.38M23.54M32.53M28.28M55.74M49.54M45.91M62.13M46.10M
Total Liabilities9.66M9.63M3.64M5.52M5.72M8.38M6.69M6.05M5.35M3.21M3.44M3.95M6.13M6.52M9.32M11.16M12.67M13.01M13.65M19.40M18.99M
Total Equity11.34M-566.06K7.34M13.06M13.93M13.77M14.60M15.61M3.66M7.76M13.10M12.46M17.25M17.02M23.20M17.12M43.07M36.54M32.26M42.73M27.11M
Cash8.66M1.40M1.20M4.21M4.61M1.54M2.04M2.35M1.22M3.27M6.44M4.59M8.69M5.85M12.66M1.87M29.25M20.30M11.73M20.57M6.63M
Total Debt7.32M6.32M1.51M2.73M2.73M6.10M4.82M3.62M2.42M245.73K197.38K-174.87K120.58K4.92M4.71M4.51M4.33M4.23M8.29M14.92M
Net Debt-1.34M6.32M306.96K-1.47M-1.88M4.56M2.78M1.27M1.20M-3.02M-6.25M-4.59M-8.51M-5.73M-7.74M2.83M-24.74M-15.96M-7.50M-12.28M8.29M

Cash Flow

Currency: AUD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.92M1.47M1.17M146.10K1.49M3.69M-90.96K563.63K369.29K706.71K4.47M4.15M654.79K-682.12K-1.11M-489.34K-8.93M-1.63M-5.68M-7.20M-12.57M-17.33M
Investing Cash Flow----1.31M-2.83M-3.10M-6.22M-753.23K-749.56K-730.71K-238.76K-651.65K-2.22M-1.14M-1.40M-820.49K-874.19K-1.16M-1.55M-508.47K-971.86K3.00M
Financing Cash Flow--6.95M867.03K4.25M-3.37M697.98K698.17K-1.21M-2.17M-326.66K-753.99K5.83M-352.45K8.09M-985.96K30.17M-725.64K-1.02M22.22M-1.12M
Capital Expenditure20.00K90.00K18.00K404.01K2.04M2.73M5.47M276.04K749.56K663.50K19.44K12.41K1.80M641.10K206.10K477.28K530.98K1.16M1.55M538.00K971.86K1.99M
Free Cash Flow----257.91K-557.03K959.00K-5.56M287.59K-380.28K43.21K4.45M4.14M-1.14M-1.32M-1.31M-966.62K-9.47M-2.79M-7.23M-7.74M-13.55M-19.32M
Dividends Paid---------278.31K278.31K278.31K556.62K600.12K651.47K660.50K752.42K881.32K882.59K884.83K0-
FCF to OCF----176.53%-37.48%25.98%6113.86%51.02%-102.98%6.11%99.57%99.70%-174.16%193.99%118.61%197.54%105.94%171.25%127.26%107.47%107.73%111.50%
Dividend Paid to FCF---------644.10%6.26%6.72%-48.81%-45.35%-49.60%-68.33%-7.95%-31.58%-12.21%-11.44%0.00%-

Earnings

Report DateFeb 24, 2016Aug 19, 2016Feb 22, 2017Aug 28, 2017Feb 26, 2018Aug 23, 2018Feb 26, 2019Aug 22, 2019Feb 25, 2020Aug 25, 2020Feb 24, 2021Aug 22, 2021Feb 23, 2022Aug 16, 2022Feb 20, 2023Mar 27, 2025Aug 24, 2025Feb 22, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00----0.00--
EPS Actual0.080.000.01-0.020.00-0.010.01-0.040.00-0.07-0.01-0.04-0.01-0.03-0.04-0.05-0.07-0.09
Surprise------------------
Timing--After-hoursPre-market--After-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap55.32M
Enterprise Value53.39M
Trailing P/E0.00
Forward P/E116.28
PEG Ratio0.00
Price / Sales1.61
Price / Book1.82
EPS-0.16
Book Value0.253
Revenue (TTM)34.42M
Gross Profit (TTM)19.46M
EBITDA-16.34M
Profit Margin-53.23%
Operating Margin-47.95%
Return on Equity-53.92%
Return on Assets-20.30%
Shares Outstanding125.73M
Shares Float64.60M
Beta0.59
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20232×
0.01Sep 1, 20230.01Mar 27, 2023
20222×
0.01Sep 2, 20220.01Apr 4, 2022
20212×
0.01Sep 3, 20210.01Apr 1, 2021
20202×
0.01Sep 4, 20200.01Mar 30, 2020
20192×
0.01Sep 6, 20190.01Apr 5, 2019
20182×
0.01Sep 7, 20180.01Apr 6, 2018
20172×
0.01Sep 1, 20170.00Mar 31, 2017
20162×
0.00Sep 2, 20160.00Apr 11, 2016
20151×
0.00Oct 2, 2015

Stock Splits

  • May 28, 20121:5